TCL Archive Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation February 29, 2008
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Clinical Trials Streamlining Moves Forward; NCI Commits To Full Funding For Groups October 9, 1998